





































































































































































































































































































































































































































































































































































































































affected,	 supracrestal	presentation	of	 the	 infraoccluded	 teeth,	bilateral	presentation,	








































































































































































































































































































































































Gene	 Forward	Primer	(5’-3’)	 Reverse	Primer					(5’-3’)	 Annealing	(°C)	 Reference	
BMP-2	 atggattcgtggtggaagtg	 gtggagttcagatgatcagc	 58	 	7	
BMP-4	 agcagccaaactatgggcta	 tggttgagttgaggtggtca	 60	 	20	
BMP-6	 cgtgaaggcaatgctcacct	 cctgtggcgtggtatgctgt	 64	 	6	
RANKL	 ctatttcagagcgcagatggat	 tatgagaacttgggattttgatgc	 61	 	16	


















































































































































































































































































































15.68	 Negative	 15.66	 Negative	 Negative	 Negative	
Patient	A,	
#19	
15.8	 Negative	 18.78	 Negative	 Negative	 14.54	
Patient	B,	
#1	
15.54	 Negative	 15.14	 Negative	 Negative	 Negative	
Patient	B,	
#16	
13.74	 Negative	 Negative	 14.17	 Negative	 Negative	
Patient	B,	
#17	

















BMP-4	 15.66	 15.68	 -0.02	
Patient	A,	#19,	
BMP-4	 18.78	 15.8	 2.98	
Patient	A,	#19,	
PTH1R	 14.54	 15.8	 1.26	
Patient	B,	#1,			BMP-
4	 15.14	 15.54	 -0.4	
Patient	B,	#16,	
BMP-6	 14.17	 13.74	 0.43	
	
	 Candidate	gene	BMP-4	was	found	to	be	expressed	at	a	higher	rate	with	respect	to	
GAPDH	across	all	positive	samples	with	exception	of	Patient	A’s	ankylosed	tooth	(#19).	
Candidate	gene	BMP-6	was	expressed	at	a	higher	rate	compared	to	GAPDH	for	Patient	B’s	
affected	upper	PFE	tooth,	#16.	Candidate	gene	PTH1R	was	expressed	at	a	higher	rate	than	the	
housekeeping	gene	in	the	ankylosed	tooth	of	Patient	A	only	at	a	higher	rate	than	the	
housekeeping	gene.		
Discussion.		
	
	
Bone	Morphogenetic	Proteins	are	key	players	in	many	processes	of	bone	metabolism	
such	as	formation,	repair,	regeneration,	healing	and	callus	formation.	Although	the	
physiological	process	of	bone	turnover	involves	at	least	200	different	elements	that	influence	
the	cells	of	bone	metabolism,	such	as	osteoblasts	and	osteoclasts,	and	interact	with	one	
another	as	well	7,	BMPs	have	been	described	as	the	most	important	factors,	together	with	
Platelet	Derived	Growth	Factor	(PTGF)	and	Transforming	Growth	Factor	Beta	(TGF-β),	in	the	
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process	of	bone	healing	7.	Not	only	are	BMPs	important	for	bone	physiology,	but	they	have	also	
been	documented	to	regulate	apoptosis	in	many	other	types	of	tissues	5,12.	In	this	study,	the	
BMPs	studied	showed	differences	in	expression	between	each	other	and	across	the	different	
samples	provided.	Amplification	plots	with	positive	results	for	the	housekeeping	gene	GAPDH	
(Figures	4a-e)	attest	to	the	metabolic	health	of	the	primary	cell	cultures	and	viability	of	the	RNA	
sample	they	yielded	after	their	harvest	and	processing.	RANKL	was	not	found	to	be	expressed	in	
any	of	the	samples	tested	and	there	are	several	possible	explanations	to	this	finding.	Liu	et	al.	
(2005)	demonstrated	that	the	expression	of	RANKL	significantly	peaks	at	postnatal	days	9-11	in	
a	rat	animal	model	10.	Differentiation	of	progenitor	cells	into	osteoclasts	and	bone	resorption	
are	both	promoted	by	RANKL	and	the	expression	of	this	factor	could	be	regulated	in	a	time	
dependent	manner	to	coincide	with	active	eruption	of	a	dental	unit	through	bone	10.		
Furthermore,	expression	of	RANKL	in	order	to	achieve	a	burst	of	osteoclast	activity	has	also	
found	to	be	site	specific.	It	is	known	that	RANKL	is	expressed	in	both	the	dental	follicle	21	and	
alveolar	bone	18,	yet	in	knockout	mice	that	lack	RANKL,	rescue	with	a	transgene	in	B	and	T	
lymphocytes	does	not	restore	tooth	eruption	and	only	leads	to	bone	resorption	in	long	bones,	
while	alveolar	bone	does	not	show	an	increase	in	this	metabolic	process	2.	If	the	source	of	
RANKL	that	leads	to	tooth	eruption	and	resorption	in	alveolar	bone	is	the	dental	follicle	as	has	
been	theorized	in	the	literature	10,	then	the	samples	analyzed	in	this	study	would	not	be	
expected	to	show	expression	of	RANKL.	All	of	the	samples	in	this	study	came	from	teeth	that	
had	already	emerged	into	the	oral	cavity	and	they	did	not	present	a	dental	follicle	proper	any	
longer,	as	it	had	long	differentiated	into	PDL.	The	age	of	both	patients	at	the	time	of	the	study	
would	also	suggest	that	RANKL	was	not	going	through	an	expression	peak	either.		
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	 BMP-2	was	found	not	to	be	expressed	across	any	of	the	samples	tested.		We	speculate	
that	this	result	is	due	to	the	fact	that	no	active	bone	formation	was	being	induced.	BMP-2	is	
osteoinductive	and	it	has	been	shown	to	induce	osteoblast	differentiation	in	a	variety	of	cell	
types	11	,	whereas	RANKL	stimulates	progenitor	cells	to	differentiate	into	osteoclasts,	leading	to	
bone	resorption	10.	BMP-2	has	been	shown	to	down-regulate	RANKL	in	vitro	and	it	has	been	
proposed	to	promote	growth	of	alveolar	bone	around	a	dental	unit	10.	Just	like	RANKL,	
expression	of	BMP-2	has	been	shown	to	go	through	a	temporal	peak	in	a	rat	animal	model,	in	
this	case	around	day	9	post-natally	in	the	dental	follicle	17,19.	The	developmental	stage	of	the	
teeth	in	this	study	and	level	of	differentiation	of	the	dental	follicle	concur	with	the	finding	that	
BMP-2	was	not	expressed	in	any	of	the	samples	tested.		
	 BMP-6	was	only	found	to	be	expressed	in	one	of	the	PFE	affected	teeth	of	Patient	B	
(#16).		Literature	on	the	expression	of	BMP-6	across	different	bones	of	the	human	body,	such	as	
the	cranial	flat	bones,	corpus	mandibulae,	diaphysis	radii,	distal	epiphysis	radii,	alaossis	ilii,	
diaphysis	femoris	and	distal	epiphysis	femoris	has	shown	similar	results.	Kochanowska	et	al.,	in	
a	study	of	all	of	the	bones	mentioned	above,	found	the	BMP-6	gene	not	to	be	expressed	in	any	
of	the	samples	studied	during	baseline	7.	It	appears	that	the	role	of	BMP-6	is	more	closely	
associated	with	bone	repair,	leading	to	its	expression	only	as	a	response	to	a	localized	insult	7.	
We	theorize	that	the	positive	result	in	our	study	was	due	to	a	localized	insult	to	alveolar	bone	
of	tooth	#16	in	Patient	B	since	she	reported	a	previous	corticotomy	attempt	in	that	quadrant	
and	it	is	not	a	result	of	different	expression	levels	between	ankylosed	teeth	and	teeth	affected	
by	PFE	or	between	affected	teeth	and	controls,	as	this	result	was	not	observed	in	tooth	#17	of	
patient	B,	which	is	affected	by	PFE	as	well.		
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	 PTH1R	was	another	candidate	gene	with	observed	differences	in	expression	across	the	
samples	tested.	In	bone,	PTH1R	is	a	receptor	expressed	on	the	cell	surface.	Activation	of	the	
receptor	by	binding	to	its	substrate,	PTH,	leads	to	expression	of	RANKL,	which	leads	to	an	
increase	in	the	differentiation	of	osteoclasts	and	bone	resorption.	Bone	resorption	and	
remodeling	have	been	observed	to	accompany	root	replacement	resorption	in	teeth	that	suffer	
from	dental	ankylosis		3.		In	a	patient	that	suffers	from	a	tooth	with	dental	ankylosis,	such	as	
Patient	A,	PTH1R	would	be	expected	to	be	expressed	in	order	to	see	the	changes	in	vertical	
height	of	the	alveolar	bone	and	replacement	resorption	that	often	coincides	with	dental	
ankylosis.	PTH1R	was	found	to	be	expressed	in	the	putatively	ankylosed	tooth,	we	therefore	
speculate	that	this	tooth	does	not	suffer	from	PFE.	
	 BMP-4		was	found	to	be	expressed	in	all	teeth	with	the	exception	of	the	2	teeth	affected	
by	PFE	on	patient	B.		This	candidate	gene	is	important	for	bone	and	cartilage	metabolism	as	a	
member	of	the	Bone	Morphogenetic	Protein	family	7.	Specifically	to	the	craniofacial	complex,	
tooth	formation	relies	on	BMP4	expression	8and	mutations	in	this	gene	are	associated	with	
orofacial	cleft	and	microphthalmia		1.	It	is	an	especially	compelling	result	that	only	the	teeth	
affected	by	PFE	failed	to	display	any	expression	of	BMP-4,	since	not	all	of	the	genes	responsible	
for	PFE	have	been	identified	so	far.	Only	10	to	40%	of	PFE	cases	have	been	shown	to	be	familial,	
with	a	mutation	present	on	gene	PTH1R	and	not	all	causative	mutations	for	this	condition	have	
been	identified	13.	In	light	of	the	observed	expression	pattern	of	BMP-4	for	the	patients	in	this	
study,	we	propose	that	BMP-4	may	be	a	downstream	effector	in	a	pathway	affected	by	PTH1R	
mutations.	An	Ingenuity	Pathway	analysis	would	help	elucidate	this	and	should	be	done	in	
future	studies	that	also	look	at	a	RNA-SeQ	analysis	of	ankylosis	versus	PFE	affected	teeth.		
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These	and	other	future	studies	will	provide	immeasurable	insights	into	the	understanding	and	
future	translational	strategies	to	manage	PFE,	ankylosis	and	other	eruption	disorders.	
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